London Esketamine Clinic

London Esketamine Clinic is proud to be the first private clinic in the UK to offer Esketamine nasal spray to patients.

London esKetamine Clinic is a service of Dyad Medical.

In 2020 Medical and Healthcare Products Regulatory Agency (MHRA) in the UK approved Esketamine (Spravato®) as a medication that can be used in the treatment of patients who suffer from moderate to severe treatment-resistant depression.

Treatment-resistant depression is usually defined as failure to respond to two different antidepressants.

One of our expert consultant psychiatrists will see you for an assessment to confirm your diagnosis and if Esketamine is the right treatment for you.

Esketamine is taken by a nasal (nose) spray device

The treatment must be administrated in our clinic under supervision of one of our trained clinicians.